Shiyong N. Xin

Luoyang, 471003, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 45 publications

Identifying PLAU as a shared pathogenic gene in type 2 diabetes and bladder urothelial carcinoma through integrated transcriptomic analysis and machine learning for diagnostic and therapeutic value.

Identifying PLAU as a shared pathogenic gene in type 2 diabetes and bladder urothelial carcinoma through integrated transcriptomic analysis and machine learning for diagnostic and therapeutic value.

Journal: Clinical and experimental medicine

Published: April 13, 2026

The BCAA metabolism-related gene BCAT1 promotes the progression of bladder urothelial carcinoma through the PI3K/AKT/mTOR signalling pathway.

The BCAA metabolism-related gene BCAT1 promotes the progression of bladder urothelial carcinoma through the PI3K/AKT/mTOR signalling pathway.

Journal: Functional & integrative genomics

Published: November 12, 2025

MYC promotes the progression of prostate cancer by regulating CD47 to induce an immunosuppressive microenvironment.

MYC promotes the progression of prostate cancer by regulating CD47 to induce an immunosuppressive microenvironment.

Journal: Cellular and molecular life sciences : CMLS

Published: October 09, 2025

Identify the PANoptosis signature and prognostic model via a multimachine-learning computational framework for bladder urothelial carcinoma.

Identify the PANoptosis signature and prognostic model via a multimachine-learning computational framework for bladder urothelial carcinoma.

Journal: Cancer cell international

Published: September 24, 2025

SOX8/CPT2 axis regulates lipid metabolism to support enzalutamide resistance in prostate cancer.

SOX8/CPT2 axis regulates lipid metabolism to support enzalutamide resistance in prostate cancer.

Journal: Cancer cell international

Published: September 14, 2025

Targeting NXPH4/ALDH1L2 signaling suppresses enzalutamide resistance in prostate cancer.

Targeting NXPH4/ALDH1L2 signaling suppresses enzalutamide resistance in prostate cancer.

Journal: Cell death discovery

Published: July 15, 2025

Different metabolic paradigms and distribution of regulatory T cells between primary and lymph node metastasis prostate cancer.

Different metabolic paradigms and distribution of regulatory T cells between primary and lymph node metastasis prostate cancer.

Journal: CytoJournal

Published: March 10, 2025

Correction: BEX4 inhibits the progression of clear cell renal cell carcinoma by stabilizing SH2D4A, which is achieved by blocking SIRT2 activity.

Correction: BEX4 inhibits the progression of clear cell renal cell carcinoma by stabilizing SH2D4A, which is achieved by blocking SIRT2 activity.

Journal: Oncogene

Published: January 22, 2025

BCAT2 binding to PCBP1 regulates the PI3K/AKT signaling pathway to inhibit autophagy-related apoptosis and ferroptosis in prostate cancer.

BCAT2 binding to PCBP1 regulates the PI3K/AKT signaling pathway to inhibit autophagy-related apoptosis and ferroptosis in prostate cancer.

Journal: Cell death & disease

Published: November 30, 2024

Correction: ScRNA-seq revealed an immunosuppression state and tumor microenvironment heterogeneity related to lymph node metastasis in prostate cancer.

Correction: ScRNA-seq revealed an immunosuppression state and tumor microenvironment heterogeneity related to lymph node metastasis in prostate cancer.

Journal: Experimental hematology & oncology

Published: May 20, 2024

BEX4 inhibits the progression of clear cell renal cell carcinoma by stabilizing SH2D4A, which is achieved by blocking SIRT2 activity.

BEX4 inhibits the progression of clear cell renal cell carcinoma by stabilizing SH2D4A, which is achieved by blocking SIRT2 activity.

Journal: Oncogene

Published: April 26, 2024

Identification of a risk model for prognostic and therapeutic prediction in renal cell carcinoma based on infiltrating M0 cells.

Identification of a risk model for prognostic and therapeutic prediction in renal cell carcinoma based on infiltrating M0 cells.

Journal: Scientific reports

Published: March 29, 2024

Showing 1-12 of 45

Last Updated: 09/26/2026